Caliber Wealth Management (Kansas)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Caliber Wealth Management (Kansas)'s ABBV Position: Q2 2026 in Review
Caliber Wealth Management (Kansas) increased its AbbVie (ABBV) stake by 4.8% in Q2 2026, buying an estimated $161K and bringing the position to 16,265 shares worth $4.09M. The position accounts for 0.4% of the portfolio, ranked #49.
Caliber Wealth Management (Kansas) first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 2,360 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Caliber Wealth Management (Kansas) held 16,265 shares of AbbVie worth $4.09M as of Q2 2026.
- Caliber Wealth Management (Kansas) bought 750 AbbVie shares in Q2 2026, an estimated $161K.
- AbbVie made up 0.4% of Caliber Wealth Management (Kansas)'s portfolio in Q2 2026, its #49 holding.
- Caliber Wealth Management (Kansas) first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
- 2,360 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Caliber Wealth Management (Kansas)'s 13F filing for Q2 2026, filed 22 Jul 2026.